MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-12.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Not enough return history to estimate factor exposures — 35 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
Avg target $190 (last qtr, 10 analysts) → $204 (last mo, 6) (+7.1%).
Buy-rated share 92% → 100% over ~3 months (+8pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $1.11 | $1.26 | +13.5% |
| May 2026 | $1.02 | $1.09 | +6.9% |
| Feb 2026 | $1.78 | $1.93 | +8.4% |
| Nov 2025 | $1.32 | $1.50 | +13.6% |
| Aug 2025 | $0.77 | $0.97 | +26.1% |
| May 2025 | $0.73 | $0.87 | +18.5% |
| Feb 2025 | $1.26 | $1.40 | +11.1% |
| Oct 2024 | $1.14 | $1.21 | +6.1% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.7B— | $3.7B-0.3% | $4.3B+14.4% | $5.5B+30.0% | $6.4B+15.7% |
| EPS (dil.) | $2.38— | $1.67-29.8% | $1.20-28.1% | $3.11+159.2% | $4.94+58.8% |
| Free Cash Flow | $169M— | $111M-34.6% | $149M+34.6% | $295M+98.5% | $474M+60.6% |
| Gross Margin | 38.6% | 37.9%-0.7pp | 44.9%+6.9pp | 48.1%+3.3pp | 49.0%+0.9pp |
| Operating Margin | 11.8% | 8.6%-3.1pp | 8.8%+0.1pp | 11.7%+2.9pp | 14.4%+2.7pp |
| Net Margin | 8.9% | 6.3%-2.6pp | 3.9%-2.3pp | 7.9%+4.0pp | 11.0%+3.0pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$576.9M over 180 days (0 open-market buys, 21 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 9.7%/yr (revenue basis).
Base free cash flow $306M (avg FY2023–FY2025; latest year $474M) · equity value $26.8B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 60 indicates a moderately attractive stock, with the short-term score of 65 diverging from the long-term score of 54, suggesting recent strength. SN scores high on growth and momentum, driven by revenue growth of 15.7% and a 12-month return of 62.2%. However, the stock trades at a premium, with a P/E of 38.4, contributing to a lower value score of 40. Profitability is moderate, with an ROE of 26.0%, while risk factors are relatively neutral, with a beta of 1.2.